Exempting certain drugs from the part D manufacturer discount program under the Medicare program
Read this section in the full bill →
This section appears in one version only, so there is nothing to compare yet.
Section 1860D–14C(g)(2) of the Social Security Act (42 U.S.C. 1395w–114c(g)(2)) is amended— (1) in subparagraph (A), by striking and at the end; (2) in subparagraph (B), by striking the period and inserting; and; and (3) by adding at the end the following new subparagraph: (C) does not include an orally administered drug— (i) for which a new drug application was approved under section 505 of the Federal Food, Drug, and Cosmetic Act; and (ii) that has been granted a narrow exception permitting reclassification as a noninnovator multiple source drug under the Medicaid drug rebate program by the Centers for Medicare & Medicaid Services..